Your browser doesn't support javascript.
loading
Circular RNA CREBBP Suppresses Hepatic Fibrosis Via Targeting the hsa-miR-1291/LEFTY2 Axis.
Yang, Ya-Ru; Hu, Shuang; Bu, Fang-Tian; Li, Hao; Huang, Cheng; Meng, Xiao-Ming; Zhang, Lei; Lv, Xiong-Wen; Li, Jun.
Afiliação
  • Yang YR; Department of Clinical Pharmacology, Second Hospital of Anhui Medical University, Hefei, China.
  • Hu S; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, School of Pharmacy, Anhui Institute of Innovative Drugs, Anhui Medical University, Hefei, China.
  • Bu FT; Institute for Liver Diseases of Anhui Medical University, Anhui Medical University, Hefei, China.
  • Li H; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, School of Pharmacy, Anhui Institute of Innovative Drugs, Anhui Medical University, Hefei, China.
  • Huang C; Institute for Liver Diseases of Anhui Medical University, Anhui Medical University, Hefei, China.
  • Meng XM; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, School of Pharmacy, Anhui Institute of Innovative Drugs, Anhui Medical University, Hefei, China.
  • Zhang L; Institute for Liver Diseases of Anhui Medical University, Anhui Medical University, Hefei, China.
  • Lv XW; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, School of Pharmacy, Anhui Institute of Innovative Drugs, Anhui Medical University, Hefei, China.
  • Li J; Institute for Liver Diseases of Anhui Medical University, Anhui Medical University, Hefei, China.
Front Pharmacol ; 12: 741151, 2021.
Article em En | MEDLINE | ID: mdl-34887753

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article